The effect of escitalopram on biomarkers of depression in patients of multidrug resistant tuberculosis (MDR-TB) suffering with depression

Abstract

Aim To study the effect of Escitalopram on biomarkers of depression in patients of multidrug resistant tuberculosis (MDR-TB) suffering with depression. Material and Methods Total 35 diagnosed MDR TB patients were selected from Tuberculosis and Respiratory diseases department complaining depression symptoms in their MDR TB treatment follow up. These patients were referred to Psychiatry OPD for diagnosis of depression. Hamilton Depression Rating Scale (HDRS) score was computed to categorize depression as mild, moderate and severe depression. 24 MDR TB patients diagnosed with mild to moderate depression were enrolled. Escitalopram (10mg) were administered to enrolled patients already taken Standard MDR-tuberculosis treatment. Follow up was done at day 30 and day 120. Depression improvement assessed by HDRS score and biomarker alterations assessed by serum lipid profile- Serum cholesterol, Triglyceride (Tg), Low density lipoprotein (LDL), High density lipoprotein (HDL) and very low density lipoprotein cholesterol (VLDL). Data were compiled and analyzed using SPSS 20.0 and paired t – test. Result Total 19 patients had completed the study. 3 and 2 patients were lost in follow up at day 30 and 120 respectively. Baseline HDRS score (13.53 ± 2.58) were decreased at day 30 (6.11 ± 1.28) and Day 120 (3.05 ± 0.91) which were significant (p˂0.001). Lipid profile parameters were not increased significantly at any follow up. Conclusion Escitalopram drug therapy improved depression symptoms without significantly affecting the biomarkers for depression (lipid profile).

Authors and Affiliations

Vijay Kumar Singh

Keywords

Related Articles

Study of antimicrobial sensitivity and resistance of pathogens isolated from postoperative wound infection

Surgical site infection are the third most common type of healthcare acquired infections in hospitals. SSI are the most common nosocomial infection in surgical patients, contributing to perioperative morbidity, prolonge...

Ebola virus disease - A comprehensive review

Ebola virus disease (EVD) is caused by infection with Ebola virus. Ebola virus disease first appeared in 1976 in 2 simultaneous outbreaks, one in Nzara, Sudan, and the other in Yambuku, Democratic Republic of Congo. The...

In vivo Antimalarial Activity of Areal Part Extracts of Gardenia lutea and Sida rhombifolia

Malaria is an endemic disease which affects 40% of world’s population and it is distributed widely, mainly due to the multi-drug resistance developed by Plasmodium falciparum. It remains the leading cause of death among...

Cost variation analysis of various brands of oral hypolipidemic drugs available in Indian pharmaceutical market

Introduction Dyslipidemia is the most common risk factor for cardiovascular morbidity and mortality worldwide requiring lifelong therapy. Hence cost of drugs plays an important role in patient’s care necessitating the n...

Prescribing trends in the department of orthopedics of a tertiary care teaching hospital

Background Drug utilization studies are necessary to monitor the prescriptions and promote rational drug prescribing among clinicians. Orthopedics department use a wide range of drugs from varied classes to meet the nee...

Download PDF file
  • EP ID EP412867
  • DOI -
  • Views 128
  • Downloads 0

How To Cite

Vijay Kumar Singh (2017). The effect of escitalopram on biomarkers of depression in patients of multidrug resistant tuberculosis (MDR-TB) suffering with depression. International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP), 6(4), 427-433. https://europub.co.uk/articles/-A-412867